BiOasis announced siRNA breakthrough; Mystic Pharma receives patent for powdered formulation;

> Mystic Pharma received a patent Notice of Allowance for their powdered formulations of drugs patients can self-administer. Release

> A new cancer therapy research partnership has been arranged between Molecular Targeting Technologies (MTTI) and Taiwan's National Health Research Institutes (NHRI). Release

> Florida Agricultural and Mechanical University received a $100,000 grant from the National Science Foundation to use toward a pilot program launch with the National High Magnetic Field Laboratory. If the program is a success, it can lead to additional millions in funding. Release

> Up and coming biopharma, biOasis announced that it discovered a carrier peptide, Transcendpep, that can cross the blood-brain barrier, effectively delivering siRNA's to the brain. Release